in:(XING LINGYAN)
CATALYST COMPONENT FOR OLEFIN POLYMERIZATION REACTION AND CATALYST THEREOF
EP05754877.8
[GAO, Mingzhi, LIU, Haitao, LI, Tianyi, LI, Xianzhong, LI, Changxiu, LI, Jiyu, XING, Lingyan, YANG, Juxiu, MA, Jing, WANG, Xiaodong, DING, Chunmin]
6A, Huixin Dong Street,
Chaoyang District, Beijing 100029, CN
更多详情内容请
点击查看
METHOD FOR IMPROVING REPRODUCTIVE EFFICIENCY OF SURROGATE SOWS
ZA202208445A
[ZHANG JIAQING, WANG XIANWEI, LIU HONGBO, LU QINGXIA, LV LINGYAN, SHEN MING, SUN SHAOCHEN, REN QIAOLING, XING BAOSONG]
CN
更多详情内容请
点击查看
BATTERY CELL, BATTERY, AND METHOD AND APPARATUS FOR PREPARING BATTERY CELL
EP20827957.0
[WU, Ningsheng, XING, Chengyou, WANG, Peng, LIANG, Chengdu, LI, Quankun, KANG, Wenlong, JIANG, Lingyan, XIE, Weigan]
CN,Jiaocheng District Ningde City, Fujian 352100,No. 2, Xin'gang Road, Zhangwan Town;
更多详情内容请
点击查看
CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST COMPRISING THE SAME
MYPI20051912A
[GAOMINGZHI, XIAODONG WANG, CHUNMIN DING, IIAITAO LIU, IIANYI LI, XIANZIIONG LI, CHANGXIU LI, JIYU LI, LINGYAN XING, JUXIU YANG, JING MA]
CN;US
THE PRESENT INVENTION PROVIDES A CATALYST COMPONENT FOR POLYMERIZATION OF OLEFIN CH2=CHR, IN WHICH R IS HYDROGEN OR C1-C12 ALKYL OR ARYL, COMPRISING MAGNESIUM, TITANIUM, A HALOGEN AND AN ELECTRON DONOR COMPOUND (A) WHICH IS AT LEAST ONE SELECTED FROM THE GROUP CONSISTING OF DIBASIC ESTER COMPOUNDS OF THE FORMULA (I), AND SAID CATALYST COMPONENT OPTIONALLY FURTHER COMPRISING AN ELECTRON DONOR COMPOUND (B) SELECTED FROM THE GROUP CONSISTING OF ALIPHATIC DICARBOXYLIC ESTERS AND AROMATIC DICARBOXYLIC ESTERS, AND/OR AN ELECTRON DONOR COMPOUND (C) SELECTED FROM THE GROUP CONSISTING OF 1 ,3-DIETHER COMPOUNDS OF FORMULA (IV):
更多详情内容请
点击查看
Secondary battery, battery module, and device using secondary battery as power source
AU2020450107A
[XING CHENGYOU, LIANG CHENGDU, WU NINGSHENG, KANG WENLONG, WANG PENG, LI QUANKUN, JIANG LINGYAN]
CN
The present application relates to a secondary battery, a battery module, and a device using the secondary battery as a power source. The secondary battery comprises a housing and a top cover connected to the housing. The housing has an end portion provided with an opening. The top cover is used for covering the opening of the housing. The top cover comprises an insertion portion extending into the housing from the opening. The inner side of the end portion of the housing or the side wall of the insertion portion facing the housing is provided with a plurality of notches. The present application provides a secondary battery, a battery module, and a device using the secondary battery as a power source. The secondary battery can reduce the possibility of an electrode assembly short-circuiting, thereby improving the usage safety of the secondary battery.
更多详情内容请
点击查看
SECONDARY BATTERY, BATTERY MODULE, AND DEVICE USING SECONDARY BATTERY AS POWER SOURCE
EP20820033.7
[XING, Chengyou, LIANG, Chengdu, WU, Ningsheng, KANG, Wenlong, WANG, Peng, LI, Quankun, JIANG, Lingyan]
No. 2 Xin'gang Road
Zhangwan Town
Jiaocheng District
Ningde City, Fujian 352100, CN
The present disclosure relates to a secondary battery, a battery module, and a device using the secondary battery as a power source. The secondary battery includes a casing and a top cover for connecting with the casing. The casing includes an end portion provided with an opening. The top cover is used to cover the opening of the casing. The top cover includes an inserting portion extending into the casing from the opening. A plurality of notches are provided on an inner side of the end portion of the casing or on a side wall of the inserting portion facing the casing. In the secondary battery, the battery module, and the device using the secondary battery as a power source according to the present disclosure, the secondary battery can reduce the possibility of short circuit occurring in the electrode assembly and improve the operational safety of the secondary battery.<img id="iaf01" file="imgaf001.tif" wi="165" he="93" img-content="drawing" img-format="tif" />
更多详情内容请
点击查看
POLYOL ESTER COMPOUNDS USEFUL IN PREPARATION OF A CATALYST FOR OLEFINS POLYMERIZATION, PROCESS FOR PREPARING THE SAME AND USE THEREOF
EP03739422.8
[GAO, Mingzhi, WANG, Jun, LI, Changxiu, LI, Jiyu, LI, Tianyi, LI, Xianzhong, MA, Jing, XING, Lingyan, LIU, Haitao]
CN,Beijing 100029,6A, Huixin East Street,Chaoyang District;CN,Beijing 100013,14 Beisanhuan East Road,Chaoyang District;
更多详情内容请
点击查看
CONDUCTIVE MEMBRANE AND PREPARATION METHOD THEREOF
US17743418
[FEIYUN SUN, Jingyi Yang, Wenyi Dong, Lingyan Zhao, Dingyu Xing, Songwen Yang, Zi Song, Ji Li]
CN Shenzhen
The present application discloses a conductive membrane and a preparation method thereof, which belong to the field of membrane separation technology. The conductive membrane provided by the present application includes a porous base layer film, a porous intermediate layer film, and a porous conductive layer film which are disposed layer by layer in sequence; wherein at least some holes of the base layer film are communicated with holes of the conductive layer film through holes of the intermediate layer film, and material of the intermediate layer film is the same as material of the base layer film and of the conductive layer film. Regarding the conductive membrane provided by the present application, it can be coupled with electrochemical technology, so that the membrane exhibits new excellent properties at the same time of playing separating characteristic.
更多详情内容请
点击查看
CATALYST COMPONENT FOR OLEFIN POLYMERIZATION REACTION AND CATALYST THEREOF
EP05754877.8
[GAO, Mingzhi, LIU, Haitao, LI, Tianyi, LI, Xianzhong, LI, Changxiu, LI, Jiyu, XING, Lingyan, YANG, Juxiu, MA, Jing, WANG, Xiaodong, DING, Chunmin]
6A, Huixin Dong Street,
Chaoyang District, Beijing 100029, CN
The present invention provides a catalyst component for polymerization of olefin CH<sub>2</sub>=CHR, in which R is hydrogen or C<sub>1</sub>-C<sub>12</sub> alkyl or aryl, comprising magnesium, titanium, a halogen and an electron donor compound (a) which is at least one selected from the group consisting of dibasic ester compounds of the formula (I), and said catalyst component optionally further comprising an electron donor compound (b) selected from the group consisting of aliphatic dicarboxylic esters and aromatic dicarboxylic esters, and/or an electron donor compound (c) selected from the group consisting of 1,3-diether compounds of formula (IV):
<chemistry id="chema01" num="0001"><img id="ia01" file="imga0001.tif" wi="89" he="18" img-content="chem" img-format="tif" /></chemistry>
wherein, R<sub>1</sub>, R' and A are as defined in the description,
<chemistry id="chema02" num="0002"><img id="ia02" file="imga0002.tif" wi="86" he="36" img-content="chem" img-format="tif" /></chemistry>
wherein R<sup>I</sup>-R<sup>VIII</sup> are as defined in the description, and a catalyst comprising the catalyst component.
更多详情内容请
点击查看
COMBINATION THERAPY FOR A RAS RELATED DISEASE OR DISORDER
PCT/US2024/027781
[ARONCHIK, Ida, BLAJ, Cristina, JIANG, Lingyan, JIANG, Jingjing, LABRECQUE, Mark, LEE, Bianca, Jennifer, MENARD, Marie, QUINTANA, Elsa, SEAMON, Kyle, SEU, Lillian, SINGH, Mallika, SHIFRIN, Nataliya, Tovbis, VEMULAPALLI, Vidya, WANG, Yingyun, WEI, Xing, WELLER, Caroline, WILDES, David, E., YANG, Yu Chi, ZHUANG, Yongxian, MONTGOMERY, David]
700 Saginaw DriveRedwood City, CA 94063
The present disclosure relates to combination therapies for treating a RAS related disease or disorder (e.g., cancer). In particular, the present disclosure relates to methods of treating a RAS related disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a RAS(ON) inhibitor in combination with one or more additional therapeutic agents, pharmaceutical compositions comprising a therapeutically effective amounts of the same, kits comprising the compositions and methods of use therefor. The present disclosure relates to combination therapies for treating a RAS related disease or disorder (e.g., cancer). In particular, the present disclosure relates to methods of treating a RAS related disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a RAS(ON) inhibitor in combination with one or more additional therapeutic agents, pharmaceutical compositions comprising a therapeutically effective amounts of the same, kits comprising the compositions and methods of use therefor.
更多详情内容请
点击查看